KIT has been considered to be a marker of progenitor cells [37] and can be more expressed in preneoplastic tissue and tumors, such as gastrointestinal stromal tumor (GIST) [38], small cell lung cancer (SCLC) [39], colorectal cancer [40,41] and pancreatic neoplasms [42]. This evidence concerns the gene KIT and pancreatic neoplasm.